{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:04:39Z","timestamp":1759334679603,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jfo.2016.03.008","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T23:47:24Z","timestamp":1472168844000},"page":"691-699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Am\u00e9lioration rapide de la fonction visuelle apr\u00e8s corticoth\u00e9rapie orale \u00e0 forte dose chez des patients atteints de neuropathie optique inflammatoire"],"prefix":"10.1016","volume":"39","author":[{"given":"A.","family":"Poujade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Le Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Baudet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Edan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mortemousque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Mouriaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2016.03.008_bib0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0197-2456(93)90015-6","article-title":"Design, methods, and conduct of the optic neuritis treatment trial","volume":"14","author":"Cleary","year":"1993","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jfo.2016.03.008_bib0090","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial","volume":"109","author":"Optic Neuritis Study Group","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2016.03.008_bib0095","series-title":"Walsh and Hoyt's clinical neuro-ophthalmology","first-page":"599","article-title":"Optic neuritis","author":"Beck","year":"1998"},{"key":"10.1016\/j.jfo.2016.03.008_bib0100","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0161-6420(95)30839-1","article-title":"What we have learned from the optic neuritis treatment trial","volume":"102","author":"Beck","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.03.008_bib0105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0161-6420(13)31589-9","article-title":"Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial","volume":"100","author":"Beck","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.03.008_bib0110","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0002-9394(99)00298-6","article-title":"Global visual field involvement in acute unilateral optic neuritis","volume":"128","author":"Fang","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.03.008_bib0115","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0022-510X(86)90075-4","article-title":"Visual evoked responses and ophthalmological examination in optic neuritis: a follow-up study","volume":"75","author":"Hely","year":"1986","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jfo.2016.03.008_bib0120","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis","volume":"326","author":"Beck","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2016.03.008_bib0125","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","article-title":"The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis","volume":"329","author":"Beck","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2016.03.008_bib0130","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(15)61137-0","article-title":"Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial","volume":"386","author":"Le Page","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jfo.2016.03.008_bib0135","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1212\/WNL.52.7.1479","article-title":"A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis","volume":"52","author":"Sellebjerg","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jfo.2016.03.008_bib0140","first-page":"13","article-title":"Optic neuritis","author":"Toosy","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jfo.2016.03.008_bib0145","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0002-9394(99)00297-4","article-title":"Recovery of visual field function in the Optic Neuritis Treatment Trial","volume":"128","author":"Fang","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.03.008_bib0150","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0161-6420(87)33349-4","article-title":"Deficits in visual function after resolution of optic neuritis","volume":"94","author":"Fleishman","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2016.03.008_bib0155","first-page":"12","article-title":"Oral versus intravenous steroids for treatment of relapses in multiple sclerosis","author":"Burton","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfo.2016.03.008_bib0080","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10072-014-1982-3","article-title":"Acute optic neuritis: retinal ganglion cell loss precedes retinal nerve fiber thinning","volume":"36","author":"Huang-Link","year":"2014","journal-title":"Neurol Sci"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551216301449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551216301449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:06:28Z","timestamp":1759259188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551216301449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0181551216301449"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2016.03.008","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Am\u00e9lioration rapide de la fonction visuelle apr\u00e8s corticoth\u00e9rapie orale \u00e0 forte dose chez des patients atteints de neuropathie optique inflammatoire","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2016.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}